182 related articles for article (PubMed ID: 3112102)
1. Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination.
Shyu WC; Nightingale CH; Quintiliani R
J Antimicrob Chemother; 1987 Jun; 19(6):807-14. PubMed ID: 3112102
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
Johnson DE; Thompson B
Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
[TBL] [Abstract][Full Text] [Related]
3. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
Brion JP; Bru JP; Michallet M; Corron B; Fauconnier J
Presse Med; 1988 Oct; 17(37):1964-7. PubMed ID: 2973597
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model.
Cappelletty DM; Kang SL; Palmer SM; Rybak MJ
Antimicrob Agents Chemother; 1995 Aug; 39(8):1797-801. PubMed ID: 7486921
[TBL] [Abstract][Full Text] [Related]
5. Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.
Johnson DE; Thompson B; Calia FM
Antimicrob Agents Chemother; 1985 Dec; 28(6):735-9. PubMed ID: 3909952
[TBL] [Abstract][Full Text] [Related]
6. In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model.
Robaux MA; Dube L; Caillon J; Bugnon D; Kergueris MF; Navas D; Le Conte P; Baron D; Potel G
J Antimicrob Chemother; 2001 May; 47(5):617-22. PubMed ID: 11328773
[TBL] [Abstract][Full Text] [Related]
7. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
[TBL] [Abstract][Full Text] [Related]
8. Amikacin + ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits.
Bayer AS; Lam K; Norman D; Kim KS; Morrison JO
Chemotherapy; 1985; 31(5):351-61. PubMed ID: 3931992
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of amikacin and ticarcillin as empiric therapy in febrile neutropenic children with cancer.
Faden HS; Deshpande GN; Grossi M; Surgalla M; Ettinger LJ; Freeman AI
Med Pediatr Oncol; 1981; 9(5):501-9. PubMed ID: 7300805
[TBL] [Abstract][Full Text] [Related]
10. Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.
Moody JA; Fasching CE; Peterson LR; Gerding DN
Diagn Microbiol Infect Dis; 1987 Jan; 6(1):59-67. PubMed ID: 3100127
[TBL] [Abstract][Full Text] [Related]
11. [Resistance to antibiotic treatment produced in a model of experimental Pseudomonas aeruginosa peritonitis].
Froidefond S; Saivin S; Lemozy J; Marchou B; Auvergnat JC; Dabernat H
Pathol Biol (Paris); 1992 May; 40(5):573-82. PubMed ID: 1495846
[TBL] [Abstract][Full Text] [Related]
12. Therapy of experimental Pseudomonas endocarditis with high-dose amikacin and ticarcillin.
Choi C; Bayer AS; Fujita NK; Lam K; Guze LB; Yoshikawa TT
Chemotherapy; 1983; 29(4):303-12. PubMed ID: 6872621
[TBL] [Abstract][Full Text] [Related]
13. Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
Bayer AS; Hirano L; Yih J
Antimicrob Agents Chemother; 1988 Feb; 32(2):231-5. PubMed ID: 3129985
[TBL] [Abstract][Full Text] [Related]
14. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
Zinner SH; Dudley M; Blaser J
Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S
N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517
[TBL] [Abstract][Full Text] [Related]
16. Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients.
Verhagen C; de Pauw BE; Donnelly JP; Williams KJ; de Witte T; Janssen TH
J Infect; 1986 Sep; 13(2):125-31. PubMed ID: 3093589
[TBL] [Abstract][Full Text] [Related]
17. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Petit JC; Richard G; Burghoffer B; Daguet GL
Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
[TBL] [Abstract][Full Text] [Related]
18. Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice.
Gerber AU; Craig WA; Brugger HP; Feller C; Vastola AP; Brandel J
J Infect Dis; 1983 May; 147(5):910-7. PubMed ID: 6842025
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of ventriculitis caused by
Gofman N; To K; Whitman M; Garcia-Morales E
Am J Health Syst Pharm; 2018 Jul; 75(13):953-957. PubMed ID: 29941534
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacin.
Standiford HC; Drusano GL; Fitzpatrick B; Tatem B; Schimpff SC
Antimicrob Agents Chemother; 1984 Sep; 26(3):339-42. PubMed ID: 6439114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
